Patrick Caubel, MD

Pfizer, Inc, United States

Pfizer (Employment)sanofi (Ownership Interest includes stock, stock options, patent or other intellectual property)

Presentation(s):

• Preliminary Results from HERO-together: A Post-emergency Use Authorization Observational Cohort Study to Evaluate the Safety of the Pfizer-BioNTech COVID-19 Vaccine in US Healthcare Workers and Community Members

  Sunday, August 28, 2022
  2:30 PM – 2:45 PM CEST